Loading institutional data...
Loading institutional data...
No institutional (13F) filings cover this company, so the Overview and 13F tabs are thin. Everything drawn from its SEC filings is here.
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Ranked against 12 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRSH | $95.4B | 23.8× | 17.1× | 3.5× | 10.3% | — | 15.4% | 27.2% | 11.9% | 2.6× | 453 |
| AJG | $70.8B | 48.1× | — | 5.1× | 20.7% | — | 10.7% | 6.4% | 4.1% | — | 387 |
| AON | $68.2B | 18.9× | 18.2× | 4.0× | 9.4% | — | 21.5% | 39.5% | 15.0% | 3.1× | 324 |
| WTW | $29.9B | 19.9× | 13.4× | 3.1× | -2.2% | — | 16.5% | 20.1% | 11.2% | 1.3× | 172 |
| BRO | $23.1B | 22.1× | — | 3.9× | 22.8% | — | 17.9% | 8.4% | 5.2% | — | 216 |
| ACT | $6.5B | 10.4× | — | 5.3× | 2.8% | — | 54.6% | 12.6% | 11.1% | — | 56 |
| BWIN | $4.5B | — | 21.7× | 3.0× | 8.3% | — | -2.2% | -5.6% | -5.5% | -0.6× | 36 |
| CRVL | $4.2B | 38.4× | — | 4.3× | 7.0% | 24.3% | 11.5% | 28.0% | 28.0% | — | 61 |
| LIFE | $2.8B | 35.6× | 34.9× | 7.3× | 52.0% | 98.3% | 18.4% | -295% | -295% | -1.2× | 8 |
| TWFG | $1.5B | 50.9× | 23.6× | 5.9× | 22.0% | — | 16.6% | 49.4% | 47.1% | -2.8× | 5 |
| GSHD | $1.1B | 45.8× | 16.2× | 3.1× | 16.2% | — | 7.6% | -29.1% | 14.1% | 3.0× | 45 |
| WDH | $359M | 50.0× | 5.4× | 0.6× | 49.8% | — | 14.2% | 11.0% | 10.9% | -1.1× | 3 |
| HUIZ | $23M | — | — | 0.1× | 32.2% | 27.1% | 0.3% | 1.0% | 0.9% | -9.3× | — |
Peers = companies sharing HUIZ's sector (Insurance Agents, Brokers & Service) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
A reverse discounted cash flow is not shown for an insurer.
Funded by policyholder float, not debt. Reserve adequacy and RBC are the right questions and are not collected yet.
Classified from the filings: SIC code.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $1.4M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 7 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 1%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 7 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $226.3M 100.0% | $1.25B 100.0% | $1.20B 100.0% | $1.16B 100.0% | $2.25B 100.0% | $1.22B 100.0% | $993.3M 100.0% |
| Cost of Revenue | $1.10B 485.2% | $796.9M 63.8% | $647.4M 54.1% | $605.7M 52.3% | $1.69B 75.2% | $813.5M 66.7% | $629.5M 63.4% |
| Research & Development | $8.4M 3.7% | $62.4M 5.0% | $71.8M 6.0% | $80.9M 7.0% | $120.5M 5.4% | $49.1M 4.0% | $33.8M 3.4% |
| Selling, General & Admin | $19.5M 8.6% | $146.8M 11.8% | $119.4M 10.0% | $154.7M 13.4% | $197.6M 8.8% | $150.2M 12.3% | $161.8M 16.3% |
| Total Operating Expenses | — | — | $161.2M 13.5% | $1.20B 103.8% | $2.36B 105.1% | $1.25B 102.1% | $991.7M 99.8% |
| Operating Income | $952K 0.4% | -$21.0M -1.7% | $51.0M 4.3% | -$43.7M -3.8% | -$114.4M -5.1% | -$25.9M -2.1% | $1.6M 0.2% |
| Other Income (Expense), net | $189K 0.1% | $17.2M 1.4% | $18.4M 1.5% | $19.5M 1.7% | $12.6M 0.6% | $10.2M 0.8% | $12.7M 1.3% |
| Pretax Income | -$10.8M -4.8% | $834K 0.1% | -$70.6M -5.9% | -$33.7M -2.9% | -$107.7M -4.8% | -$16.5M -1.4% | $15.0M 1.5% |
| Income Tax Expense | $1.0M 0.5% | $135K 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $1.8M 0.1% | $57K 0.0% |
| Net Income | $578K 0.3% | -$649K -0.1% | $70.2M 5.9% | -$31.2M -2.7% | -$107.7M -4.8% | -$18.3M -1.5% | $14.9M 1.5% |
| Per Share | |||||||
| EPS (Basic) | $0.00 | $0.00 | $0.07 | -$0.03 | -$0.11 | -$0.02 | — |
| EPS (Diluted) | $0.00 | $0.00 | $0.07 | -$0.03 | -$0.11 | -$0.02 | — |
| Weighted Avg Shares (Basic) | 1.01B | 997.2M | 1.00B | 1.02B | 1.02B | 963.8M | 452.4M |
| Weighted Avg Shares (Diluted) | 1.01B | 997.2M | 1.00B | 1.02B | 1.02B | 963.8M | 452.4M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-10-30
Where each multiple sits in its own 6-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 6-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 1% against ROIC 1% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cost of Revenue | 63.4 | 66.7 | 75.2 | 52.3 | 54.1 | 63.8 | 485.2 |
| R&D | 3.4 | 4.0 | 5.4 | 7.0 | 6.0 | 5.0 | 3.7 |
| SG&A | 16.3 | 12.3 | 8.8 | 13.4 | 10.0 | 11.8 | 8.6 |
| Operating Income | 0.2 | -2.1 | -5.1 | -3.8 | 4.3 | -1.7 | 0.4 |
| Income Tax | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 |
| Net Income | 1.5 | -1.5 | -4.8 | -2.7 | 5.9 | -0.1 | 0.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on HUIZ: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Leverage ratios is not shown for an insurer.
Funded by policyholder float, not debt. Reserve adequacy and RBC are the right questions and are not collected yet.
Classified from the filings: SIC code.
How much the company owes, how it's trended, and how comfortably it's serviced.
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash of $35.9M fully covers short-term debt of $7.6M.
Mostly short-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Cost of capital cannot be computed, so the spread is unknown.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2019 | 36.6% | 0.2% | 1.5% |
| FY2020 | 33.3% | -2.1% | -1.5% |
| FY2021 | 24.8% | -5.1% | -4.8% |
| FY2022 | 39.0% | -3.8% | -2.7% |
| FY2023 | 39.0% | 4.3% | 5.9% |
| FY2024 | 31.5% | -1.7% | -0.1% |
| FY2025 | 27.1% | 0.4% | 0.3% |
Return on equity (1%) and return on invested capital (1%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: wacc.
Converts 3.81x of reported profit into cash — adequate, without much margin.
Reported free cash flow is $1M; after share-based compensation it is -$1M. The difference is a real cost that the cash flow statement adds back.
Leverage is not measurable this way for a insurer.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
Funded by policyholder float, not debt. Reserve adequacy and RBC are the right questions and are not collected yet.
Missing from our data, so excluded from this answer: capital adequacy metrics for this archetype.
No growth rate within the range this model can express reaches the current price, so the requirement cannot be stated as a number.
No material counter-signal in the checked set: reverse-DCF implied growth, historical FCF CAGR, per-year FCF growth distribution, reporting-basis breaks, discount rate used, free-cash-flow basis (stock comp charged?).
Missing from our data, so excluded from this answer: implied_growth.
| Step | Amount | Running total |
|---|---|---|
| Net income | $578,000 | $578,000 |
| Share-based comp | $3M | $3M |
| Other non-cash & working capital | −$671,000 | $3M |
| Operating cash flow | $3M | $3M |
| Capex | −$1M | $1M |
| Free cash flow | $1M | $1M |
| FCF after SBC | −$1M | −$1M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 31.1% | 37.6% | 6.5 points |
| FY2021 | 88.4% | 242.2% | 153.8 points |
| FY2022 | -52.4% | -70.2% | -17.9 points |
| FY2023 | 0.3% | -30.9% | -31.2 points |
| FY2024 | 1.6% | -14.3% | -15.9 points |
| FY2025 | 32.2% | 14.7% | -17.6 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 66.3 days | not reported | 72.2 days | -5.9 days |
| FY2020 | 69.6 days | not reported | 102.1 days | -32.5 days |
| FY2021 | 126.4 days | not reported | 147.1 days | -20.7 days |
| FY2022 | 79 days | not reported | 135.6 days | -56.6 days |
| FY2023 | 54.4 days | not reported | 106.1 days | -51.7 days |
| FY2024 | 45.9 days | not reported | 86.2 days | -40.3 days |
| FY2025 | 39.8 days | not reported | 61.7 days | -21.9 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -20.3 percent |
| FY2020 | -11.7 percent |
| FY2021 | 3.7 percent |
| FY2022 | 4.9 percent |
| FY2023 | -7.1 percent |
| FY2024 | 2.1 percent |
| FY2025 | -1.5 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 2 consecutive years to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.